FDA Investigator: Susan F. Laska

- Susan F. Laska first started conducting FDA inspections in 2000, with the last inspection in 2008. Over that time, Susan F. Laska has conducted 138 inspections at 112 companies across 117 sites.

Get Susan Laska's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 NOVAST Laboratories (China) Ltd., Nantong | 2008

Out-of-stock
Susan F. Laska
Human Drug Form 483

FDA 483 Zhejiang Xianju Pharmaceutical Co., Ltd., Zhejiang | 2008

Out-of-stock
Susan F. Laska
Human Drug Form 483

FDA 483 Guilin Pharmaceutical Co., Ltd., Guilin | 2008

Out-of-stock
Susan F. Laska
Human Drug Form 483

FDA 483 Sanofi Chimie, Aramon | 2008

Out-of-stock
Susan F. Laska
Human Drug Form 483

FDA 483 Jan Ilkowski, M.D., Poznan | 2007

Out-of-stock
Susan F. Laska
Human Drug Form 483

FDA 483 Prof. Andrzej Szczudlik, Krakow | 2007

Out-of-stock
Susan F. Laska
Human Drug Form 483

FDA 483 Grzegorz Maciej Opala, M.D., Ph.D., Prof., Katowice | 2007

Out-of-stock
Susan F. Laska
Human Drug Form 483

FDA 483 Endo Pharmaceuticals, Inc., Malvern | 2007

Out-of-stock
Susan F. Laska
Human Drug Form 483

FDA 483 DENTSPLY CAULK, Milford | 2007

Out-of-stock
Susan F. Laska
Medical Devices & Rad Health Form 483

FDA 483 Biospectra, Inc., Stroudsburg | 2007

Out-of-stock
Susan F. Laska
Human Drug Form 483

FDA 483 Pfizer GmbH, Freiburg | 2007

Out-of-stock
Susan F. Laska
Human Drug Form 483

Co-Investigators (44)